Related Experiment Video
Updated: Mar 23, 2026

Knee Arthrocentesis in Adults
Published on: February 25, 2022
The influence of VKORC1 and CYP2C9 mutations on warfarin response after total hip and knee arthroplasty
Eric S Wise1, Stephen P Gadomski2, William G McMaster1
1Department of Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-2730, USA.
Aims:
This study characterizes the influence of genotype at two loci on warfarin response after arthroplasty.
Methods:
121 postarthroplasty patients given warfarin thromboprophylaxis were reviewed for international normalized ratio (INR) values on the first three days postoperatively. Significant differences among genotypes in INR values on each of the first three postoperative days were assessed.
Results:
Wild-type patients at both loci (∼23% of patients) had yet to reach therapeutic INR (1.5-2.0) by postoperative day three more frequently than those with a mutation conferring hyper-responsiveness (61% vs. 30%; P ≤ .01).
Conclusions:
Wild-type patients are not anticoagulated in a sufficiently prompt manner after arthroplasty.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Venous Thrombosis III: Interprofessional Care
Pharmacogenetics of Drug Metabolism: Overview
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Anticoagulant Drugs: Low-Molecular-Weight Heparins